Generic ( Lapatinib )

Typical use Of Lapatinib :Treatment Of Patients With Advanced Or Metastatic Breast Cancer Whose Tumors Overexpress The Human Epidermal Receptor Type 2 (HER2) Protein And Who Have Received Prior Therapy Including An Anthracycline, A Taxane, And Trastuzuma.
Mechanism of action of Lapatinib :Lapatinib Inhibits The Tyrosine Kinase Activity Associated With Two Oncogenes, EGFR (epidermal Growth Factor Receptor) And HER2/neu (Human EGFR Type 2). Over Expression Of HER2/neu Can Be Responsible For Certain Types Of High-risk Breast Cancers In Women. Lapatinib Is A Protein Kinase Inhibitor Shown To Decrease Tumor-causing Breast Cancer Stem Cells. Lapatinib Inhibits Receptor Signal Processes By Binding To The ATP-binding Pocket Of The EGFR/HER2 Protein Kinase Domain, Preventing Self-phosphorylation And Subsequent Activation Of The Signal Mechanism.
Drug Interaction of Lapatinib :Lapatinib Is Known To Interact With Other Drugs Like Artemether, Etravirine, Pazopanib, Tacrolimus, Telithromycin, Topotecan, Tramadol, Tretinoin, Voriconazole, Ziprasidone. Always Consult Your Physician For The Change Of Dose Regimen Or An Alternative Drug Of Choice That May Strictly Be Required.
Side effects of Lapatinib :Diarrhea, Nausea, Vomiting, Palmarplantar Erythrodysesthesia, Rash, Fatigue.


How Lapatinib will impact on Pregnancy ?

Experiences Of Drug Use And Evidence From Studies In Pregnant Women Have Shown Risk To Fetus. This Drug May Be Used In Pregnant Women If Benefit Outweighs The Risk. Patients Should Follow The Advice Of The Doctor Regarding Its Use.

How Lapatinib will impact during lactation(breastfeeding) ?

Contraindicated: The Drug Should Not Be Used By Breastfeeding Women, As Evidences From Studies Have Shown That There Is A High Risk Of Causing Significant Damage To Infants.

Medicine & Alcohol use and effect of Lapatinib

No Studies Found